CureTech Overview

  • Founded
  • 2001
  • Status
  • Out of Business
  • Latest Deal Type
  • Liquidation
  • Financing Rounds
  • 9

CureTech General Information


Developer of immune modulating products for the treatment and control of cancer. The company's immune modulating products offer antibodies and peptide-based vaccines to modulate anti-cancer activities, attenuate tumor growth and eliminate tumor metastases in a variety of model systems and exhibits anti-cancer immune response against tumors and pediatric brain cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 42 Hayarkon Street
  • Yavne 81227
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CureTech Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CureTech‘s full profile, request access.

Request a free trial